Present Absent P value
Clinicocytological variables Group 1 Group 2 Total%)    
Mucositis n=1(2.9%) n=0(0%) n=1(2.9%) n=3497%) 0.56
Oral ulcers n=2(5.7%) n=0(0%) n=2(5.7%) n=33(94.3%) 1.0
Oral hairy leukoplakia n=1(2.9%) n=0(0%) n=1(2.9%) n=34(97.1%) 1.0
Chronic periodontitis  n=9(25.7%) n=0(0%) n=9(25.7%) n=26(74.3%) 0.30
Oral wart n=1(2.9%) n=0(0%) n=1(2.9%) n=34(97.1%) 1.0
 Oral pigmentation n=20(57.1%) n=2(5.7%) n=22(62.9%) n=1337.14%) 0.34
Pseudomembranous Candidiasis n=1(2.9%) n=1(2.9%) n=2(5.7%) n=33(94.3%) 0.27
Inflammation n=2160%) n=2(5.7%) n=23(65.7%) n=12(34.3%) 0.31
Dysplasia n=6(17.1%) n=0(0%) n=6(17.1%) n=29(82.9%) 0.56
Fungi n=16(45.7%) n=1(2.8%) n=17(48.5%) n=18(51.5%) 0.82
Micronuclei n=16(45.7%) n=3(8.6%) n=19(54.3%) n=16(45.7%) 1.0
Nuclear Atypia n=13(37.1%) n=0(0%) n=13(37.1%) n=22(62.9%) 0.13
Association between different clinicopathological variables and viral load groups in n=35 patients. (Chi-square tests). Note no significant association (p>0.05) was seen between clinicopathological variables and viral load group.
Table 2: Comparison of clinicocytological variables with viral load groups in patients on ART.